Elehear Alpha vs Otofonix Groove

The Elehear Alpha is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $299, it sits in the most affordable price tier for over-the-counter devices, though its overall performance ranks #44 of 65 OTC hearing aids tested. This behind-the-ear device presents a distinctive performance profile with notable strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.2/5—a strong result that's 2.28 points above the category average. Feedback handling is also excellent at 5.0/5, meaning users can expect stable performance without whistling issues. However, core speech understanding metrics fall below category norms: speech in quiet scores a mixed 2.1/5 (0.73 points below average), while speech in noise is low at 1.0/5 (0.48 points below average). Own-voice comfort is a significant limitation, scoring just 0.7/5—a low result that's 1.81 points below the category average. This suggests users may experience noticeable occlusion effects when speaking. The Elehear Alpha is best suited for budget-conscious consumers who prioritize music and media streaming over speech clarity in challenging environments. Those needing stronger speech performance should consider alternatives like the Elehear Beyond or Olive Union Air, which offer better sound scores at similar or lower price points. For users primarily streaming podcasts, audiobooks, or music who have modest speech amplification needs, the Alpha's excellent streaming quality and feedback stability may justify its trade-offs.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.